Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2026 Jul 1;46(8):e70769. doi: 10.1111/liv.70769

Correction to ‘A Markov Model Unveiling the Impact of Resmetirom on the Natural History of MASLD Patients: A Sistematic Review and Meta‐Analysis’

PMCID: PMC13679463  PMID: 42387868

Pennisi G., Di Maria G., Enea M., et al., “A Markov Model Unveiling the Impact of Resmetirom on the Natural History of MASLD Patients: A Sistematic Review and Meta‐Analysis,” Liver International 45, no. 4 (2025): e70056. 10.1111/liv.70056.

The Funding section of the originally published article contained an incomplete project reference.

The original funding statement has been replaced with the following text:

‘Funded by the European Union ‐ Next Generation EU–NRRP M6C2 ‐ Investment 2.1 Enhancement and strengthening of biomedical research in the NHS. Project Cod. PNRR‐MAD‐2022‐12375656, title “RATIONAL: Risk stratification Of Nonalcoholic fatty Liver” – CUP: I75E22000540006’.

We apologize for this error.


Articles from Liver International are provided here courtesy of Wiley

RESOURCES